Measures included sociodemographics (age, sex, race, neighborhood deprivation index [NDI]), duration of HIV status, Charlson Comorbidity Index (CCI), HIV RNA, CD4 cell counts, higher risk tobacco use (TAPS tobacco score ≥ 2), depression, and anxiety symptoms. This evidence concerns the gene CD4 and depressive symptom measurement.